CardioComm Solutions, Inc

CardioComm Press Releases
News & Media


September 24, 2013


CardioComm Solutions Talks With The Wall Street Analysts

CEO Interview reviews opportunities in both the consumer and medical ECG services market

TORONTO, ONTARIO – CardioComm Solutions, Inc. (CardioComm Solutions) (TSX VENTURE: EKG) confirms that a recent interview with the Wall Street Analyst (WSA) will be featured on the front page of for two business days. The interview with Etienne Grima, the Company’s Chief Executive Officer, will be made available to their global investor audience which includes fund managers, analysts, investment bankers, individual investors, and members of the financial press.  

“The purpose of this interview was to provide an overview of the impact of the Company’s recent news developments, to provide the investment community a viewpoint on opportunities and challenges in the health monitoring market sector and to describe how CardioComm Solutions is being positioned to capitalize on those opportunities. The interview also gave us an opportunity to overview our products and services, both current and planned, and to provide a glimpse of our future growth strategies,” stated Mr. Simi Grosman, member of the Board of Directors for the Company.

“This interview allowed us to review the 17 months since our initial HeartCheckTM PEN product clearance and to provide a window on new opportunities and new product and technology lines that we see coming.  The +40 year old consumer with risk factors for atrial fibrillation (AF) and stroke is our primary consumer target market. During 2013 we have worked to broaden use of the HeartCheckTM and SMART Monitoring technologies as easy to use and cost effective solutions for large scale and individual screening efforts as a means to find AF and to prevent stroke.  We are now  also targeting pharmacists and health fitness providers as an important channel to help expand ECG screening through a HeartCheckTM ECG Screening Partner Program which will allow for access to those individuals currently under prescription therapies as well as those interested in preserving their health,” said Etienne Grima, Chief Executive Officer for CardioComm Solutions. “Finally, the interview also provided an opportunity to confirm that we are actively engaged in developing new medical ECG management software solutions, an example of which will meet the needs of the US-based mobile cardiac telemetry market.”

The WSA is a multi-media financial research and publishing company reporting to the investment community on publicly held companies. They service a large following of private and institutional investors that look for promising small and micro cap opportunities, accessing an investment community across markets and continents using print, web, audio, streaming video, email alerts, electronic and syndicated news story distribution, Investment conferences, and Chartered Financial Analyst (CFA) analyst coverage.

About CardioComm Solutions
CardioComm Solutions’ patented and proprietary technology is used in products for recording, viewing, analyzing and storing electrocardiograms (ECGs) for diagnosis and management of cardiac patients.  Products are sold worldwide through a combination of an external distribution network and a North American-based sales team.  The Company has earned the ISO 13485 certification, is HPB approved, HIPAA compliant, and has received FDA market clearance for its software devices.  CardioComm Solutions is headquartered in Toronto, Canada, with offices in Victoria, B.C.  

Etienne Grima, Chief Executive Officer
1-877-977-9425 x227

Forward-looking statements

This release may contain certain forward-looking statements with respect to the financial condition, results of operations and business of CardioComm Solutions and certain of the plans and objectives of CardioComm Solutions with respect to these items. By their nature, forward-looking statements involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future and there are many factors that could cause actual results and developments to differ materially from those expressed or implied by these forward-looking statements.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.


  download pdf  
Investor Information
CEO Updates
Investor Information

CardioComm Solutions stock is one of the most actively traded stocks on the TSX and TSX Venture Exchange

read article


"About 80 clinics in Ontario and across Canada have signed onto Cardiocomm's C4 arrythmia service since it was launched in 2009"

read article

" With a history of excellence in the Medical industry reaching back to the early 1990s, the medical software company, CardioComm Solutions, Inc. (CardioComm) continues to be a leader in ECG management technologies."
read article

"Hidden strengths thrive in the local tech market "

read article

Globe and Mail Investors -- Price Reports

read article

EKG CardioComm Solutions Inc

read article

Is a Tech Revival Happening on the TSX Venture Exchange?

read article

ECG test may signal heart attack risk in elderly

read article

Usefulness of Continuous Electrocardiographic Monitoring for Atrial Fibrillation

read article

Arrhythmia EKG Management | 12 Lead ECG Management | ECG Software | EKG Management | Web Based ECG | EKG Software